Pacific Biosciences of California (STU:P09) Accounts Payable & Accrued Expense : €39.6 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Pacific Biosciences of California Accounts Payable & Accrued Expense?

Pacific Biosciences of California's quarterly accounts payable & accrued expense increased from Sep. 2023 (€47.6 Mil) to Dec. 2023 (€55.7 Mil) but then declined from Dec. 2023 (€55.7 Mil) to Mar. 2024 (€39.6 Mil).

Pacific Biosciences of California's annual accounts payable & accrued expense increased from Dec. 2021 (€41.8 Mil) to Dec. 2022 (€42.1 Mil) and increased from Dec. 2022 (€42.1 Mil) to Dec. 2023 (€55.7 Mil).

Pacific Biosciences of California Accounts Payable & Accrued Expense Historical Data

The historical data trend for Pacific Biosciences of California's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Biosciences of California Accounts Payable & Accrued Expense Chart

Pacific Biosciences of California Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

19.45

17.20

41.83

42.13

55.73

Pacific Biosciences of California Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															34.34	40.17	47.57	55.73	39.56

Pacific Biosciences of California Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Pacific Biosciences of California (STU:P09) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (STU:P09) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

PACB:USA

Address

1305 O’Brien Drive, Menlo Park, CA, USA, 94025

Website

https://www.pacb.com

Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.

Pacific Biosciences of California (STU:P09) Headlines

No Headlines